How to show Utilization Break-up [Regulatives / Guidelines]

posted by sachin_bhandurge – India, 2013-11-01 08:21 (4617 d 16:00 ago) – Posting: # 11852
Views: 4,320

(edited on 2013-11-01 12:03)

Dear All,
I wan to conduct Comparative BA study in India,BE for Export purpose for EU market regarding that purpose, I want to Import Investigational Drug products from out of India to conduct Comparative BA studies Fasting with 32 subjects and Fed with 32 subjects.

To apply for Import license we need to show Utilization Break-up as per DCGI norms.

Can you please help me out in calculating and showing Utilization Break-up i.e., No of samples required for the study and No. of sample required for Retention.

I have already calculated as below:

Example: Fasting Study (Test product)

Samples Required for Study:
Dosing (32) + verification purpose (2) and extra dispensed (2) = 36 samples

Samples Required for Retention:
Dissolution Profile (12 ×2 times) = 34 × 2 (time points) = 68 samples

I am confused in calculating No of sample required for retention considering number sample required for dissolution profile, If the above calculation is incorrect I request to give easy formula to calculate the same is meeting regulatory requirements also.


Regards
SACHIN



Edit: identical post in a separate, unrelated thread deleted [Ohlbe]

PREM

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
136 visitors (0 registered, 136 guests [including 21 identified bots]).
Forum time: 01:22 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5